Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
Paola Secchiero, Federica Corallini, Claudio Ceconi et al. · 2009
Read Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction by Paola Secchiero, Federica Corallini, Claudio Ceconi et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004442.txt.
Description
A blood protein called TRAIL may help predict how heart attack patients fare, report Paola Secchiero, Federica Corallini, Claudio Ceconi, and co-authors in PLOS ONE in 2009. In lab and animal work, the soluble form of TRAIL calms inflammation and slows artery disease. That made it a candidate marker worth testing in real patients.
The team measured TRAIL levels in the blood of people who had just had a heart attack. They then compared those levels with how the patients did afterward. As the title signals, lower levels after the attack carried a poor outlook. A simple blood test that flags high-risk patients early could help doctors aim closer care at those who need it most.
Catalog record
| CREATOR | Paola Secchiero, Federica Corallini, Claudio Ceconi et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004442